Decibel Therapeutics Inc - ESG Rating & Company Profile powered by AI
Check the bottom of the page for potential risks for Decibel Therapeutics Inc based on industry, location and marketcap. This page contains a zero-cost E,S&G analysis covering Decibel Therapeutics Inc. The report of Decibel Therapeutics Inc leverages intelligence from across the internet as well as from public filings by Decibel Therapeutics Inc.
Decibel Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.3; made up of an environmental score of 2.7, social score of 3.2 and governance score of 4.0.
3.3
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1234 | Quanterix Corp | 3.4 | Medium |
| 1234 | X4 Pharmaceuticals Inc | 3.4 | Medium |
| 1253 | Decibel Therapeutics Inc | 3.3 | Medium |
| 1253 | Calithera Biosciences Inc | 3.3 | Medium |
| 1253 | Cara Therapeutics Inc | 3.3 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Decibel Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Decibel Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Decibel Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Decibel Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Decibel Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Decibel Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Decibel Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Decibel Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Decibel Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Decibel Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Decibel Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Decibel Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Decibel Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Decibel Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Decibel Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Decibel Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Decibel Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Decibel Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Decibel Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Decibel Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Decibel Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Decibel Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Decibel Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Decibel Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Decibel Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Decibel Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Decibel Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Decibel Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Decibel Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Decibel Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Decibel Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Decibel Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Decibel Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Decibel Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Decibel Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Decibel Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Decibel Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to address hearing disorders caused by single gene mutations; Gene Therapies for Hair Cell Regeneration designed to replace lost hair cells within the inner ear to address acquired hearing loss and balance disorders; and Otoprotection Therapeutic in clinical development to prevent hearing loss in cancer patients undergoing chemotherapy with cisplatin. The company's lead gene therapy product candidate is DB-OTO to provide hearing to individuals born with profound hearing loss due to mutation of the otoferlin gene. It is also developing DB-ATO and AAV.201, a gene therapy program designed to restore balance in patients with bilateral vestibulopathy by regenerating lost hair cells within the vestibule; DB-020 for the prevention of cisplatin-induced hearing loss, which is in Phase 1b clinical trial; AAV.103 to restore hearing in individuals with a gap junction beta-2 (GJB2) deficiency; AAV.104 to restore hearing in individuals with stereocilin (STRC) deficiency; and cochlear hair cell regeneration program, an AAV-based gene therapy that utilizes cell-selective expression of reprogramming factors to convert supporting cells into outer hair cells. Decibel Therapeutics, Inc. has a strategic collaboration with Regeneron Pharmaceuticals, Inc. to develop gene therapies for monogenic forms of congenital hearing loss. The company was formerly known as Hearing Inc. and changed its name to Decibel Therapeutics, Inc. in April 2014. Decibel Therapeutics, Inc. was incorporated in 2013 and is headquartered in Boston, Massachusetts.